Healthcare Providers and Services
Company Overview of Renal Care Group, Inc.
Renal Care Group, Inc. provides dialysis services to patients with chronic kidney failure, also known as end-stage renal disease (ESRD). It provides its services for the treatment of chronic and acute renal diseases. The company also provides ancillary service, which is the administration of erythropoietin, also known as Epogen, a bioengineered protein that stimulates the production of red blood cells. The company was founded in 1995 and is headquartered in Nashville, Tennessee. As of March 31, 2006, Renal Care Group, Inc. operates as a subsidiary of Fresenius Medical Care AG & Co. KGAA.
2525 West End Avenue
Nashville, TN 37203
Founded in 1995
Key Executives for Renal Care Group, Inc.
Compensation as of Fiscal Year 2014.
Renal Care Group, Inc. Key Developments
Fresenius Medical Care Announces Successful Completion of Legal Matters with United States Government Against Renal Care Group
Dec 21 12
Fresenius Medical Care AG & Co. KGAA announced that the United States government's litigation against Renal Care Group, Inc. in connection with 'Method II' Medicare reimbursement has successfully concluded with the Department of Justice's filing of a stipulation of dismissal. The end of this litigation also concludes the broader investigation begun by the government in St. Louis, Missouri in 2005. The Department of Justice investigated many areas of the company's operations under subpoenas issued in St. Louis beginning in April 2005. In July 2007, after two years of investigation, the Department initiated litigation on a single topic of the investigation: that Renal Care Group, which the company had acquired by merger, violated the False Claims Act by maintaining a 'Method II' subsidiary. In 2011, a federal trial court in Tennessee entered judgment against the company for $83 million. In October 2012, however, the United States Court of Appeals reversed and vacated the judgment. The Court of Appeals further ruled against the Department of Justice on several significant issues of law raised by the case, agreeing with the company that it was not unlawful for Renal Care Group to maintain a subsidiary that billed under Method II. The Court of Appeals then remanded the case to the trial court to allow the Department to proceed to trial on remaining, unresolved issues. By its filing, the Department confirmed that it would not pursue the remand and would litigate no further.
Federal Appeals Judge Overturns $82.6 Million Fresenius Judgment
Oct 8 12
A federal appeals court has overturned an $82.6 million judgment against a former Nashville-based dialysis company. Renal Care Group, which was acquired by Fresenius Medical Care Holdings Inc. of Germany in 2005, was the focal point of one of the area's large Medicare billing cases. The company was accused of improperly billing the Medicare program for home dialysis supplies and equipment between 1999 and 2005. Renal Care, then one of the country's large diabetic supply companies, was ordered to pay $82.6 million in damages. In 2010, Fresenius appealed that decision, denying any wrongdoing and reiterating that the company had discussed the structure of its operations with government officials.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries